Funder
Shiraz Transplant Research Center, Shiraz University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Microbiology
Reference51 articles.
1. Karadkhele G, Hogan J, Magua W, Zhang W, Badell IR, Mehta A et al (2021) CMV high-risk status and post-transplant outcomes in kidney transplant recipients treated with Belatacept. Am J Transplant 21(1):208–221. https://doi.org/10.1111/ajt.16132
2. Jarque M, Crespo E, Melilli E, Gutiérrez A, Moreso F, Guirado L et al (2020) Cellular immunity to predict the risk of cytomegalovirus infection in kidney transplantation: a prospective, interventional, multicenter clinical trial. Clin Infect Dis 71(9):2375–2385. https://doi.org/10.1093/cid/ciz1209
3. Soleimanian S, Yaghobi R, Karimi MH, Geramizadeh B, Roozbeh J (2022) Loss of CCR7 expression on CD57+ CD56/CD16+ NK cells correlates with viral load in CMV reactivated kidney transplant recipients. Iran J Kidney Dis 1(1):52–62
4. Martín-Gandul C, Pérez-Romero P, Sánchez M, Bernal G, Suárez G, Sobrino M et al (2013) Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection. J J Clin Virol 56(1):13–18. https://doi.org/10.1016/j.jcv.2012.09.017
5. Bolovan-Fritts CA, Trout RN, Spector SA (2007) High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage. Blood 110(6):1857–1863. https://doi.org/10.1182/blood-2007-03-078881
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献